Advances in Thrombosis Diagnosis and Antithrombotic Therapy
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 November 2026 | Viewed by 902
Special Issue Editors
Interests: acute coronary syndromes; thrombosis; cardiovascular prevention; percutaneous coronary intervention
Special Issues, Collections and Topics in MDPI journals
2. Division of Cardiology, Città della Salute e della Scienza Hospital, Turin, Italy
Interests: coronary artery disease; cardiac CT; acute coronary syndrome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue will focus on the evolving landscape of thrombosis diagnosis and antithrombotic therapy, with a particular emphasis on acute coronary syndromes, high-risk cardiovascular settings, and patients with complex comorbidities. Recent progress in diagnostic tools, including biomarkers, advanced imaging, and artificial intelligence, has enabled a more precise stratification of thrombotic risk and treatment needs. This issue welcomes original research, reviews, and perspectives on emerging pharmacological strategies, individualized therapeutic approaches, and future directions in integrating diagnostics and therapy in thrombosis care.
You may choose our Joint Special Issue in the Journal of Cardiovascular Development and Disease.
Dr. Ovidio De Filippo
Dr. Fabrizio D’Ascenzo
Guest Editors
Dr. Francesco Antonio Veneziano
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antithrombotic therapy
- ischemic heart disease
- risk stratification
- personalized medicine
- dual antiplatelet therapy
- bleeding risk
- coronary artery disease
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
